Blume Capital Management, Inc. Sanofi Transaction History

Blume Capital Management, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 02, 2024	BUY	$45.75 - $52.48 $398,482 - $457,100	8,710 New	8,710 $423,000
Q1 2022 May 12, 2022	SELL	$48.48 - $53.65 $2.54 Million - $2.81 Million	-52,400 Reduced 99.62%	200 $10,000
Q4 2021 Feb 07, 2022	BUY	$47.07 - $52.35 $2.43 Million - $2.7 Million	51,600 Added 5160.0%	52,600 $2.64 Million
Q3 2021 Nov 12, 2021	SELL	$47.89 - $53.12 $23,945 - $26,560	-500 Reduced 33.33%	1,000 $48,000
Q2 2021 Aug 10, 2021	SELL	$49.36 - $54.25 $10,957 - $12,043	-222 Reduced 12.89%	1,500 $79,000
Q1 2021 May 10, 2021	BUY	$45.46 - $50.51 $78,282 - $86,978	1,722 New	1,722 $85,000

822

268M

1.9M

Ticker SNY
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,508,100,096
Market Cap $121B
Description
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...

Get notified when there are updates to the investment portfolio of Blume Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Blume Capital Management, Inc. with notifications on news.